Tag Archives: Ahead

“Navigating maritime digital transformation relies on stable connectivity,” says KebNi ahead of CabSat 2020

“As the maritime industry invests 4.77 billion USD by 2025 on satellite communication to increase efficiency and improve services, sustaining a reliable internet connection is fundamental to every maritime asset”, says KebNi COO Claus Nielsen, ahead of CabSat 2020 next week Stockholm, Sweden, November 6th, 2020 – “The flow of data within maritime is revolutionising… Read More »

5 top cyber hygiene tips to help organizations stay ahead of cyberthreats

Telling IT teams to patch vulnerabilities faster when they are already strapped for time may not help organizations get ahead of the increasing cyberthreat landscape. Similar to how an individual would not go to the dentist only once their teeth began falling out, an organization should not wait until a breach to get serious about… Read More »

To stem coronavirus crisis, scientists forge ahead on 6 key fronts

This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education and policy stories related to the SARS-CoV-2 pandemic and the disease COVID-19. From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations… Read More »

Get Ready for Clocks to ‘Spring Ahead’

By Kayla McKiski HealthDay Reporter FRIDAY, March 6, 2020 (HealthDay News) — If losing an hour of sleep with the switch to Daylight Saving Time on Sunday leaves you feeling tired, you’re not alone. Fifty-five percent of Americans feel the same way, according to an American Academy of Sleep Medicine (AASM) survey. For most Americans,… Read More »

AstraZeneca, Merck's Lynparza plows ahead in ovarian cancer with $1B-plus approval, phase 3 data

The year may be winding down, but AstraZeneca and Merck’s Lynparza sure isn’t. It picked up a blockbuster new approval late Wednesday and followed up the act by posting positive phase 3 data Thursday morning. U.S. regulators green-lighted the fast-growing PARP inhibitor in BRCA-mutated ovarian cancer patients who’ve responded partially or completely to an initial… Read More »